Hemophilia B, a recessive X-linked coagulopathy, is rare in females, and only a few cases have been reported so far. In this report, we describe a 9-year-old female, offspring of a consanguineous marriage, with a clinically severe course of hemophilia B and a normal 46,XX karyotype. Polymerase chain reaction and conformation sensitive gel electrophoresis techniques have been applied to the important regions of the factor IX gene,and an abnormal conformation sensitive gel electrophoresis profile was identified in exon 5 of the gene. After sequencing, the mutation was found to be C17761T (R116X) in homozygous form. Then, polymerase chain reaction-restriction fragment length polymorphism using the Eco RV restriction enzyme was applied for confirmation of the homozygous mutation in the proband and for carrier testing in the relatives. In addition, haplotype analysis was informative at the Hha Ipolymorphic site for the female patient.

Keywords:
Conformation sensitive gel electrophoresis, Factor IX gene mutation, Hemophilia B
1.
Thompson AR: Structure, function and molecular defects of factor IX. Blood 1986;67:565.
2.
Bolton-Maggs PHB, Pasi KJ: Haemophilias A and B. Lancet 2003;361:1801–1809.
3.
Yoshitake S, Schach BG, Foster DC, Davie EW, Kurachi K: Nucleotide sequence of the gene for human factor IX (antihemophilic factor B). Biochemistry 1985;24:3736–3750.
4.
Bowen DJ: Haemophilia A and haemophilia B: molecular insights. Mol Pathol 2002;55:127–144.
5.
Lillicrap D: The molecular basis of haemophilia B. Haemophilia 1998;4:350–357.
6.
Espinos C, Lorenzo JI, Casana P, Martinez F, Aznar JA: Haemophilia B in a female caused by skewed inactivation of the normal X-chromosome.Haematologica 2000;85:1092–1095.
7.
King S, Coffey AJ, Ljung R, Sjörin E, Nilsson IM, Holmberg L, Giannelli F: Moderate haemophilia B in a female carrier caused by preferential inactivation of the paternal X chromosome. Eur J Haematol 1991;47:257–261.
8.
Orstavik KH, Orstavik RE, Schwartz M: Skewed X chromosome inactivation in a female with haemophilia B and in her non-carrier daughter: a genetic influence on X chromosome inactivation. J Med Genet 1999;36:865–866.
9.
Schroder W, Wulff K, Wolling K, Herrmann FH: Haemophilia B in female twins caused by a point mutation in one factor IX gene and non-random inactivation patterns of the X-chromosomes. Thromb Hemost 1997;78:1347–1351.
10.
Chan V, Chan VW, Yip B, Chim CS, Chan TK: Haemophilia B in a female carrier due to skewed inactivation of the normal X-chromosome. Am J Hematol 1998;58:72–76.
11.
Miller SA, Dykes DD, Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
12.
Hinks JL, Winship PR, Makris M, Preston FE, Peake IR, Goodeve AC: A rapid method for haemophilia B mutation detection using conformation sensitive gel electrophoresis. Br J Haematol 1999;104:915–918.
13.
Williams IJ, Abuzenadah A, Winship P, Preston FE, Dolan G, Wright J, Peake IR, Goodeve AC: Precise carrier and prenatal diagnosis in females with haemophilia A: use of conformation sensitive gel electrophoresis for rapid mutation screening and polymorphism analysis. Thromb Haemost 1998;79:723–726.
14.
Peake IR, Lillicrap DP, Boulyjenkov V, Briet E, Chan V, Ginter EK, Kraus EM, Ljung R, Mannucci PM, Nicolaides K, Tuddenham EGD: Report of a WHO/WFH meeting on the control of haemophilia: carrier detection and prenatal diagnosis. Blood Coagul Fibrinol 1993;4:313–344.
15.
Giannelli F, Green PM, Sommer SS, Poon M, Ludwig M, Schwaab R, Reitsma PH, Goossens M, Yoshioka A, Figueiredo MS, Brownlee GG: Haemophilia B: database of point mutations and short additions and deletions – eighth edition. Nucleic Acids Res 1998;26:265–268.
16.
Krepischi-Santos ACV, Carneiro JDA, Svartman M, Bendit I, Odone-Filho V, Vianna-Morgante AM: Deletion of the factor IX gene as a result of translocation t(X;1) in a girl affected by haemophilia B.Br J Haematol 2001;113:616–620.
17.
Schroder W, Poetsch M, Gazda H, Werner W, Reichelt T, Knoll W, Rokicka-Milewska R, Zieleniewska B, Herrmann FH: A de novo translocation 46,X, t(X;15) causing haemophilia B in a girl: a case report. Br J Haematol 1998;100:750–757.
18.
Saadat M, Ansari-Lari M, Farhud D: Cosanguineous marriage in Iran. Ann Hum Biol 2004;31:263–269.
19.
Saadat M: Cosanguineous marriage in Iranian folktales. Community Genet 2007;10:38–40.
© 2008 S. Karger AG, Basel
2008
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.